HomeIMRX • NASDAQ
add
Immuneering Corp
Previous close
$5.33
Day range
$5.17 - $5.67
Year range
$1.10 - $10.08
Market cap
362.88M USD
Avg Volume
892.18K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 13.75M | -25.89% |
Net income | -11.58M | 35.85% |
Net profit margin | — | — |
Earnings per share | -0.18 | 68.97% |
EBITDA | -13.67M | 25.97% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 172.83M | 378.16% |
Total assets | 231.99M | 340.08% |
Total liabilities | 13.50M | 19.18% |
Total equity | 218.48M | — |
Shares outstanding | 64.65M | — |
Price to book | 1.58 | — |
Return on assets | -14.54% | — |
Return on capital | -15.14% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -11.58M | 35.85% |
Cash from operations | -9.84M | 32.18% |
Cash from investing | -88.72M | -1,715.84% |
Cash from financing | -357.52K | -772.26% |
Net change in cash | -98.92M | -991.71% |
Free cash flow | -14.67M | -49.93% |
About
Founded
2008
Website
Employees
53
